All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is likely that we see a gap up on Monday and a solid downtrend from there. Like and follow for more biotech ideas like this :) Happy Trading!
[I]Remember that these are biotech stocks and there are no guarantees in this sector. Proceed with caution![/I]
Unfortunately, ONCY crapped the bed over the weekend. We had one spike this morning and then it tanked. It might be a great opportunity to buy but it was a typical "pump and dump" this morning. There is some support around the $3.45 mark but if it blows through that support, I suspect it'll go right back down to around the $3.00 mark. That being said, the overall trend is upwards so this isn't a "get rich quick" stock but it is moving upwards. It looks horrible on the 1-Hour chart but better on the 1-week chart. However, I don't make my trades or investments based upon the 1-week interval. I day trade, snipe, and scalp so I watch the 1-minute, 5-minute, and 15-minute intervals mostly.
I wish I knew how to post a picture in this response because the chart shows an ascending wedge of sorts. That could bode well for the company. We shall see. I have my finger on the "buy" button but I'm watching closely to see how it pans out first.
Best wishes in all of your trading. Stay in the green!
Investor4321
⋅
Thank You! I am holding GLYCPIRS and ONCY. Great Analysis!
I wish I knew how to post a picture in this response because the chart shows an ascending wedge of sorts. That could bode well for the company. We shall see. I have my finger on the "buy" button but I'm watching closely to see how it pans out first.
Best wishes in all of your trading. Stay in the green!